Northern Trust Corp Atossa Therapeutics, Inc. Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 263,377 shares of ATOS stock, worth $226,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares

263,377

Previous 973,998 72.96%

Holding current value

$226,504

Previous $652,000 66.56%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$0.59 - $1.03 $419,266 - $731,939	-710,621 Reduced 72.96%	263,377 $218,000
Q1 2025 May 13, 2025	SELL	$0.67 - $1.01 $34,656 - $52,243	-51,726 Reduced 5.04%	973,998 $652,000
Q4 2024 Feb 14, 2025	BUY	$0.94 - $1.62 $67,233 - $115,870	71,525 Added 7.5%	1,025,724 $964,000
Q3 2024 Nov 13, 2024	BUY	$1.09 - $1.52 $748,820 - $1.04 Million	686,991 Added 257.1%	954,199 $1.45 Million
Q2 2024 Aug 14, 2024	BUY	$1.03 - $2.1 $42,782 - $87,225	41,536 Added 18.41%	267,208 $317,000
Q1 2024 May 14, 2024	SELL	$0.8 - $1.89 $1,800 - $4,252	-2,250 Reduced 0.99%	225,672 $406,000
Q4 2023 Feb 13, 2024	BUY	$0.63 - $0.98 $8,366 - $13,014	13,280 Added 6.19%	227,922 $200,000
Q2 2023 Aug 11, 2023	SELL	$0.6 - $1.28 $500 - $1,067	-834 Reduced 0.39%	214,642 $270,000
Q1 2023 May 15, 2023	SELL	$0.59 - $0.91 $2,813 - $4,338	-4,768 Reduced 2.16%	215,476 $155,000
Q3 2022 Nov 14, 2022	BUY	$0.82 - $1.14 $1,053 - $1,464	1,285 Added 0.59%	220,244 $183,000
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.28 $669,792 - $1.01 Million	-787,991 Reduced 78.26%	218,959 $239,000
Q1 2022 May 13, 2022	SELL	$1.11 - $1.74 $47,217 - $74,016	-42,538 Reduced 4.05%	1,006,950 $1.26 Million
Q4 2021 Feb 08, 2022	SELL	$1.6 - $3.27 $52,848 - $108,008	-33,030 Reduced 3.05%	1,049,488 $1.68 Million
Q3 2021 Nov 15, 2021	SELL	$2.89 - $6.4 $119,455 - $264,537	-41,334 Reduced 3.68%	1,082,518 $3.53 Million
Q2 2021 Aug 13, 2021	BUY	$1.52 - $8.62 $1.49 Million - $8.43 Million	978,204 Added 671.62%	1,123,852 $7.1 Million
Q1 2021 May 12, 2021	BUY	$0.92 - $4.33 $124,132 - $584,233	134,927 Added 1258.53%	145,648 $307,000
Q2 2020 Aug 14, 2020	SELL	$1.04 - $4.05 $1,880 - $7,322	-1,808 Reduced 14.43%	10,721 $41,000
Q3 2019 Nov 13, 2019	BUY	$1.96 - $2.52 $24,556 - $31,573	12,529 New	12,529 $25,000

Others Institutions Holding ATOS

# of Institutions

Shares Held

28.6M

Call Options Held

12.7K

Put Options Held

92.9K

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $109M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Atossa Therapeutics, Inc. Transaction History